D
uring fetal life, congenital heart disease is typically suspected either by obstetric ultrasound examination or specialist fetal echocardiography. Over recent years, the outflow tract views have been integrated into routine fetal screening. 1, 2 For many forms of congenital heart disease, the primary diagnosis is not based on the size of heart structures but by recognition of abnormal cardiac connections. However, for some cardiac lesions, notably coarctation of the aorta, pulmonary valve stenosis, and aortic valve stenosis, the size of vessels is an important consideration both for diagnosis and prognosis. [3] [4] [5] [6] It can be extremely important to compare an observed size of a valve or vessel to a size expected at a particular gestational age (GA). 7 One method of assessing potential deviation from normality is by the use of z scores which describe the number of gestation-specific SDs a given measurement lies from the gestation-specific mean. 8 The impact of this method of assessment is well described in fetal cardiology particularly with respect to prediction of postnatal development of coarctation of the aorta, early neonatal intervention in tetralogy of Fallot and of single versus biventricular repair in cases of critical left or right ventricular outflow tract obstruction, 5, 6, [9] [10] [11] [12] [13] [14] [15] and identification of suitable cases for fetal cardiac intervention. [16] [17] [18] Reference ranges of fetal outflow tracts have been published previously, but the number of cases examined was small ranging from 130 to 390. [19] [20] [21] Lee at al 22 published a series of 2735 cases, but measurements of the aortic and ductal arches were not reported. The objective of this study is to report reference ranges for the diameter of fetal aortic valve, pulmonary valve, arterial duct, and distal transverse aortic arch (DTAA) and the ratio of DTAA: arterial duct from the study of 7945 fetuses who had measurements made prospectively at a single tertiary fetal cardiology center.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure but can be available on request. All fetal echocardiograms performed or reported by a fetal cardiologist between 2002 and 2015 were identified from the departmental database (Viewpoint version 5.6, General Electric Healthcare) at Harris Birthright Center for Fetal Medicine at King's College Hospital, London, United Kingdom. The center serves the local population and also receives tertiary referrals for fetal medicine, including fetal cardiology, predominantly from the South East of England. Fetal echocardiography is performed for a wide variety of predefined indications, including family history of congenital heart disease, elevated nuchal translucency, or suspected congenital heart disease. Measurement of the size of the aorta, pulmonary artery, ductal arch, and aortic arch was part of the cardiac protocol throughout the study period, and all measurements were made prospectively. In all cases, pregnancy dating was based on an ultrasound measurement of the fetal crown-rump length at 11 to 13 weeks' gestation. This was a cross-sectional study and measurements of the outflow tracts from each fetus were taken only once. Pregnancy outcome was obtained from the hospital records, general practitioners, or the parents.
Inclusion Criteria
The inclusion criteria were singleton pregnancies with fetal echocardiography at 13 to 36 weeks' gestation, resulting in the live birth of phenotypically normal babies.
Exclusion Criteria
The exclusion criteria were GA <13 and >36 weeks' gestation, prenatal, or postnatal diagnosis of any form of congenital heart disease or variant of normal cardiac anatomy (persistent left superior vena cava, aberrant right subclavian artery, interrupted inferior vena cava, left atrial isomerism,
CLINICAL PERSPECTIVE
Before birth, congenital heart disease is typically suspected by recognition of abnormal cardiac anatomy during screening or specialist ultrasound examination. However, for lesions such as coarctation of the aorta, pulmonary stenosis, or aortic stenosis, the size of the outflow tracts relative to that expected at a particular gestational age is an important consideration both for diagnosis and prognosis. We report gestation-specific reference ranges and z scores for the cardiac outflow tracts from a phenotypically normal population of >7000 fetuses between 13 and 36 weeks' gestation. The pulmonary and aortic valves were measured in diastole at maximal diameter when closed thus enabling visualization of the valve. Previously, measurement of the aortic isthmus was described, but technically this structure is not identifiable on standard transverse views and thus, we describe the measurement of the distal transverse aortic arch at its widest systolic diameter made on the 3 vessel and tracheal view beyond the trachea. Regression analysis, with polynomial terms to assess for linear and nonlinear contributors, was used to establish the relationship between each measurement and gestational age. Gestation-specific SDs were calculated. We have established reference ranges for fetal outflow tract measurements which should prove useful in clinical practice. They may provide further insight into the natural history of valve lesions in fetal life and provide increased confidence of normal ranges in size across a wide gestational age range.
malposition of the heart), major extracardiac defect, chromosomal abnormality, genetic syndrome, termination of pregnancy, and intrauterine or neonatal death.
Measurements
All fetal echocardiograms were reviewed contemporaneously by a fetal cardiologist and measurements were made prospectively at the time of the scan (Drs Vigneswaran, Zidere, Charakida and Professors Allan, Simpson). Our scanning protocol uses a series of transverse views to assess the 4 chamber view and outflow tracts consistent with published recommendations. 1 The left and right ventricular outflow tracts were assessed using this approach, and the aortic arch and ductal arch were assessed in the 3 vessel and tracheal view as shown in Figure 1 . Measurements were made with the ultrasound beam orthogonal to the plane of the vessel where possible, but other projections were used if fetal lie was less favorable. Online measurements were made of the aortic valve, pulmonary valve, DTAA, and arterial duct diameters using electronic calipers. Our policy was to measure the semilunar valves at their largest diameter in diastole with the valve closed so that the exact position of the valve was clear. Measurements were made from inner edge to inner edge on 2-dimensional (2D) echocardiography. The aortic arch was measured at its most distal point beyond the trachea at the widest systolic diameter (DTAA). This region is often referred to as the aortic isthmus in fetal life, but as the relationship to the left subclavian artery and arterial duct cannot be determined on this view, we have referred to it as the DTAA. The arterial duct was measured on the same view at its widest systolic diameter (Figure 1 ). Measurements were made only where the relevant structure could be visualized adequately at the time of the scan so not all measurements could be made in every patient. Echocardiograms were performed using the Acuson Aspen Advanced (Acuson, Mountain View, CA) with a 4 to 7 MHz curvilinear probe or a Voluson E8 (GE Medical Systems, Zipf, Austria) with a 4 to 8 MHz or 6 MHz curvilinear probe appropriate to the GA.
Statistical Analysis
A reference range for fetal echocardiographic measurements was established from the study population of pregnancies with live births that fulfilled the inclusion criteria. The distributions for each fetal cardiac measurement were assessed for Gaussian normality by inspecting histograms and probability plots. Transformation of data were considered if the distribution of the variable was non-Gaussian. In case of each measurement, the mean and SD of the normally distributed data were estimated. The study population for development of reference range was selected for each cardiac measurement by excluding outliers outside the mean±3 SD. The selected population after exclusion of outliers was reassessed to ensure Gaussian normality as described above. Regression analysis was used to examine the association of each cardiac measurement with GA at measurement. Before the regression analysis, the GA was centered by subtracting the arithmetic mean from the GA in weeks to minimize effects of multicollinearity associated with introduction of polynomial terms in the regression analysis. 23 The relationship between the dependent variable for each cardiac measurement and the independent variable of GA was assessed for linear and nonlinear trends by introducing polynomial terms in the regression analysis to determine the best fit. The significance of contribution of variables was assessed by examination of P values and effect size. The effect size of the coefficients was assessed by calculating Cohen's d (coefficient/SD) and partial η 2 from the multivariate regression analysis. Effect size of Cohen's d ≤0.2 and partial η 2 ≤0.01 was considered small. The final model was selected based on the terms that provided a significant contribution in prediction of the cardiac measurement. To determine the parametric reference centiles, we estimated whether the SD was constant or was dependant on the GA at measurement by regression analysis of the residuals on estimated mean value of the cardiac measurement using linear and nonlinear terms. The fitted SD was then estimated by multiplying the expected absolute residuals derived from the regression analysis by √π/2, where π=3.14159. The observed measurement for each cardiac measurement was then expressed as a z score (difference between observed and expected value divided by the fitted SD corrected for GA) and percentile. The reference range for each measurement were constructed using the fifth, 10th, 50th, 90th, and 95th percentiles. The statistical software package SPSS 24.0 (IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp, 2016) and Medcalc, version 15.0 (Medcalc Software, Ostend, Belgium) were used for the data analyses. Institutional review board approval was not required as all data were collected for clinical purposes according to a defined clinical protocol and consent was not required.
RESULTS
During the study period 17 292 fetal echocardiograms were performed and 7945 of these fulfilled the inclusion criteria. The indications for fetal echocardiography are shown in Table 1 . The ethnicity of the mother was recorded as: white (n=6139), Afro-Caribbean (n=1102), South Asian (n=343), East Asian (n=191), and mixed race (n=170). The number of cases analyzed for each variable were aortic valve: 7544, pulmonary valve: 7535, arterial duct: 6176, DTAA: 6176, and DTAA: arterial duct ratio 6176. All variables showed Gaussian distribution ( Figure 2 ) and therefore transformation was not required. A polynomial regression equation using GA provided the best fit for all the data. Increasing the order beyond a squared analysis showed no significant improvement in the fit of the model for the aortic valve, pulmonary valve, DTAA, and arterial duct measures. The coefficients for the regression equations are provided in Table 2 and further data  are available in Tables I through V 
DISCUSSION
This study has established reference ranges for fetal outflow tract measurements from 13 to 36 weeks' gestation. The strengths of the study include first, examination of a large number of fetuses in all 3 trimesters of pregnancy; second, accurate pregnancy dating based on the measurement of fetal crown-rump length in the first trimester; and third, inclusion of fetuses with known normal outcome and exclusion of those with abnormalities which were only apparent after birth and furthermore, prospective recording of measurements according to a defined protocol under the supervision of a team of fetal cardiologists. In previous studies the number of fetuses examined was very small and in the case of z score for the aortic arch the number was <400; [19] [20] [21] second, in one study pregnancy dating was based on menstrual age, 22 which can be inaccurate; and third, in some studies postnatal outcome was not ascertained. 19, 22 The prospective approach used in our study avoided the potential selection bias of retrospective studies which can result in inclusion of only the best images. This approach, however, may carry its own confirmation bias because each study is performed by the individual operators for a known specific indication; the mindset of the operator might be different if he or she were simply performing the measurements to collect data. In the development of reference ranges there is a balance between accurate sampling with one observer using very strict methodology and of multiple observers that accounts for the variability in quantification among observers.
We included measurements from fetuses of diabetic mothers and those with an isolated increased nuchal translucency thickness, provided there were no cardiac Family history of congenital heart disease 705
Maternal diabetes mellitus 454
Maternal anti-Ro antibodies 40
Suspected congenital heart disease 1014
Maternal exposure to teratogenic drug 170
Advanced maternal age 44
Potential rhythm disturbance 90
Heart difficult to image 514
Tricuspid regurgitation at first-trimester scan 675 or extracardiac defects, and the pregnancies resulted in live births with no abnormalities. We deliberately included such fetuses because they constitute a high proportion of referrals for specialist fetal echocardiography and their exclusion may skew the reference ranges or make them nonapplicable. Previous studies have excluded fetuses of diabetic mothers 21, 22 and those with increased nuchal translucency thickness. [20] [21] [22] From a technical perspective, the measurement of the arterial valves was made with the valve closed and therefore the valve was visible making the measurement straightforward. This is in contrast to measurement during systole where the valve is not visible, but the exact approach and preference will vary by institution. Measurement of the distal aortic arch was performed on the 3 vessel and tracheal view and z scores are provided for this mode of measurement. Other studies have used sagittal measurements which have the advantage that the head and neck vessels may be visualized. However, sagittal views do not permit side by side comparison of the ductal and aortic arches and visualization is more dependent on the fetal lie than the 3 vessel and tracheal view which has been widely adopted during screening. 1 Finally, we used a standard statistical methodology which was used to create fetal reference measurements and z scores which vary with gestation. 23 To create accurate z scores and centiles we used linear and nonlinear trends in a large series of patients to derive not just the regressed means, but also to derive accurate estimates of variance by examining the relationship of residuals with GA using linear and polynomial trends. with a demonstration of 1st, 5th, 50th, 95th, and 99th centiles. The measurement of the aortic and pulmonary valves was made in diastole at the largest diameter with the valve closed. The distal transverse aortic arch was measured on the 3 vessel and tracheal view beyond the trachea at the distal point at its widest systolic diameter. The arterial duct was measured on the 3 vessel and tracheal view at its widest systolic diameter.
The reference ranges for cardiac outflow tracts and z scores presented in this study can be applied in the assessment of patients with cardiac asymmetry, pulmonary stenosis, right ventricular outflow tract obstruction, or aortic stenosis 2, 3, 5, 10, 11, 13, 15, 16, 18, [24] [25] [26] [27] [28] [29] [30] [31] [32] ; in these cases knowledge of the accurate z score can aid in predicting the need for neonatal intervention and to plan perinatal management. Z scores may also be useful in forecasting the natural history of valve stenosis and in designing clinical trials on the value of in utero valvuloplasty, where patients can be stratified according to z scores. 5, 10, 33, 34 A separate issue is whether measurement of the outflow tracts should constitute part of routine screening for prenatal diagnosis of outflow tract abnormalities. Published guidelines on fetal echocardiography 1,2,35 by several professional bodies recommend assessment of relative size of outflow tracts, but such assessment does not stipulate actual measurement. Our reference ranges could be used as part of future prospective studies that compare subjective versus objective measurements of size. Ideally, our z scores would need to be validated in an unselected population-based cohort before they are utilized within screening programs.
Limitations
The study population was not derived from routine screening in pregnancy but from fetuses examined in a fetal cardiology clinic. Although we excluded cases of fetal abnormalities and adverse pregnancy outcome, it is possible that the values obtained may not be truly representative of those in an unselected normal population. A further limitation is that in most patients normality was determined from a clinical examination in the neonatal period and it is possible that some genetic syndromes or chromosomal abnormalities may have not been diagnosed at this stage. In terms of major cardiac defects, we are confident that these would not have been missed as all babies with such defects are referred to our regional pediatric cardiac surgical center and thus feedback to the fetal medicine unit is provided.
Conclusions
The study has established reference ranges for fetal cardiac arterial measurements at 13 to 36 weeks' gestation that would assist both fetal medicine specialists and fetal cardiologists in clinical practice. The z scores can be used to assist in confirming normality, identifying deviation from normal dimensions, or providing prognostic information.
